Innovation, brand power, and digital skills have benefited Colgate-Palmolive Company (NYSE:CL). The company’s strict pricing policies and fast revenue growth management strategies continue to pay off. As a result, the second quarter of 2022 produced remarkable results, with earnings and sales exceeding the consensus estimate from Zacks.
A 5.5% increase in net sales to $4,484 million was seen from the prior quarter. Sales for the company increased by 9% organically. This quarter saw organic sales increase for the fourteenth time in a row, with pet nutrition and oral care seeing double-digit increases. As a result, shares of Colgate have increased by 1% over the last three months while declining by 1.8% for the sector.
However, the company is not immune to fluctuations in the price of raw materials and unfavorable currency fluctuations. Let’s explore this further.
What’s Effective for Colgate?
Colgate’s innovation strategy aims to expand into related product categories and market niches. In addition, it is concentrating on significant developments that will premiumize its array of oral care products. Products like CO. by Colgate, Colgate Elixir toothpaste, and Colgate enzyme whitening toothpaste have been working well because they are supported by premium innovation.
Some noteworthy initiatives include the acquisition of Hello Products LLC, the ongoing growth of the Naturals and Therapeutics divisions, and collaboration with Philips to launch electric toothbrushes in Latin America under the co-brand Philips Colgate.
The geographic reach of Colgate’s brands is aggressively expanded, coupled with improved distribution through quicker growth channels. It has increased the scope of its portfolio by introducing drugstore names like Elmex and Meridol to newer areas. Elta MD and PCA Skin, two of its professional skincare companies, are doing well in spas and dermatology offices.
With the acquisition of the Filorga skincare company, Colgate also increased the scope of its premium skincare offering. It is profiting from significant market share growth in its two biggest markets, North America and China, as well as growing share growth in all other regions.
With a sales increase of 14.5% in the second quarter and organic sales growth of 18%, Hill’s business is still seeing strong sales growth. Results improved due to a 5.5% rise in reported and organic unit volumes and a 12.5% rise in prices, which were somewhat offset by a 3.5% negative currency impact. Gains in the United States, Europe, and Australia/New Zealand helped organic sales.
Strength in pet nutrition and oral care continues to be a key growth driver. Prescription Diet Derm Complete, the company’s recently introduced product, has increased market share and will probably be distributed abroad in the upcoming quarters. In light of the growing number of consumers who utilize online services for their fundamental needs, Colgate continues to concentrate on increasing the accessibility of its products through the e-commerce channel.
Due to these factors, management expects net sales growth in 2022 to be closer to the upper range of its previously stated 1-4% growth. Compared to the earlier projected 4-6% growth, organic sales growth is anticipated to reach 5-7%.
Colgate Is Facing Headwinds
The bottom line performance in the second quarter of 2022 was negatively impacted by the company’s struggle with rising raw material and logistics costs worldwide. Despite the second-quarter 2022 profit surprise, the adjusted non-GAAP earnings of $0.72 per share for Colgate’s Base Business were down 10% from the same period a year earlier. GAAP earnings dropped 13% to $0.72 per share in the period under consideration. For 2022, a mid-single-digit fall in adjusted earnings is predicted.
Furthermore, rising advertising expenditures continue to be problematic. On both a GAAP and adjusted basis, advertising investments are anticipated to increase year over year for 2022. On both a GAAP basis and an adjusted basis, this will probably reduce the gross margin in 2022. Inflation in packaging and raw materials of $1.3 billion, as well as greater logistic expenses, are other factors that Colgate anticipates for 2022.
Moving forward, the adverse effects of foreign exchange and excessive debt levels remain obstacles for Colgate.
Bottom Line
We think Colgate’s strategic initiatives, such as its ambitions for expansion, brand strength, and product innovation, will help counteract cost pressures. A profits growth rate of 4.6% over the long term encourages optimism for the stock. In the past 30 days, Colgate’s earnings projections for 2022 have increased by a penny to $3.03.
Featured Image : Megapixl © Wellesenterprises
